Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Bradford T. Whitmore currently holds 1,941,759 shares of Clearside Biomedical, Inc. (CLSD), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Bradford T. Whitmore has been a net buyer of CLSD stock. They have purchased $83.2M and sold $76.3M worth of shares.
Bradford T. Whitmore's most recent insider trade was on Mar 16, 2026, when they purchased 53,131 shares at $6.76 per share.
Bradford T. Whitmore serves as Executive at Clearside Biomedical, Inc. (CLSD). They have executed 662 insider transactions totaling $159.4M over their tenure at the company.
Bradford T. Whitmore holds the position of Executive at Clearside Biomedical, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Bradford T. Whitmore has shown a buying trading pattern, with $83.2M in total purchases and $76.3M in total sales across all transactions. Their most recent activity indicates a tendency to accumulate shares.
The largest transaction by Bradford T. Whitmore was on Mar 1, 2024, when they purchased $6.0M worth of NANX shares. This transaction involved 15,000 shares at $400.00 per share.
Bradford T. Whitmore currently owns 1,941,759 shares of Clearside Biomedical, Inc. (CLSD), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Bradford T. Whitmore's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Bradford T. Whitmore has 662 Form 4 filings on record as an insider at Clearside Biomedical, Inc..
Set alerts for Bradford T. Whitmore and 40,000+ other insiders.